Small-molecule Cathepsin K inhibitors: a medicinal chemistry perspective

  • Future Med Chem. 2025 Jul;17(14):1757-1770. doi: 10.1080/17568919.2025.2542717.
Xuan Guan  1  2 Shu Cheng  1 Yifei Yin  1 Shufang Du  1
Affiliations
  • 1. State Key Laboratory of Oral Diseases, West China School of Stomatology, National Clinical Research Center for Oral Diseases, Sichuan University, Chengdu, China.
  • 2. Tianfu Jiangxi Laboratory, Chengdu, Sichuan, China.
Abstract

Cathepsin K (Cat K) is a member of the Cathepsin family and is found in a wide range of tissues. Cat K is involved in the terminal catabolism and recycling of endocytosed proteins, as well as specific cellular processes and a wide range of diseases. It is predominantly expressed in osteoclasts and has potent collagenase activity. Based on its particular structure and biological functions, Cat K inhibitors with precise targeting and good penetration are potential therapeutic approaches for related diseases. In this paper, we introduce the structure and biological functions of Cat K and focus on Cat K inhibitors with therapeutic potential for human diseases.

Keywords
Cathepsin K; drug design; molecular binding modes; small molecule inhibitors; structure-activity relationships (SAR).